HOME >> BIOLOGY >> NEWS
Tumor Oxygen Level And Blood Flow Fluctuate, Duke Scientists Discover

PHILADELPHIA -- In a discovery that might help explain why widely used cancer therapies are less than optimal, Duke University Medical Center researchers have found that a tumor's oxygen level and blood flow can fluctuate rapidly. The Duke animal study, which contradicts previous assumptions about tumors, could be important because the two major cancer treatments, radiation and chemotherapy, depend on a constant high oxygen level and steady blood flow within a tumor, scientists said. "These fluctuations in oxygen level and blood flow are not predictable and might represent an impediment to radiation therapy and drug therapy," said Mark Dewhirst, co-director of the radiation oncology and hyperthermia program at Duke Comprehensive Cancer Center and associate professor of pathology. "Before this work, there was no way to reliably measure these values."

Dewhirst prepared the findings for presentation Tuesday at an American Association for Cancer Research meeting. His study, which was done in collaboration with Rod Braun, assistant professor in radiation oncology, was funded by the National Cancer Institute. A report based on the results of this study has been accepted for publication by the American Journal of Physiology. High oxygen levels are crucial for effective radiation therapy, Dewhirst explained, because radiation kills tumor cells by forming oxygen radicals -- highly reactive oxygen atoms that damage DNA.

Chemotherapy might be affected by the fluctuations, Dewhirst said, because if tumor blood flow drops, the drugs might not be delivered efficiently throughout the tumor.

While low oxygen levels, called hypoxia, are known to exist in certain tumors, researchers had not measured changes in oxygen levels over time. In the current study, Dewhirst and his colleagues measured oxygen levels in mammary tumors in seven rats using an electrochemical probe that produces an electrical current depending on the amount of oxygen present in the tissue.

T
'"/>

Contact: Joanna Downer
downe010@mc.duke.edu
919-684-4148
Duke University Medical Center
14-Apr-1999


Page: 1 2 3

Related biology news :

1. Tumor cell-specific therapy shows preclinical promise
2. Tumor cells made more sensitive to radiation by blocking a key cellular molecule
3. Discovery Of 13 Genes Expressed In Brain Tumors May Lead To More Effective Diagnosis Or Prevention
4. Dietary Lutein Inhibits Mammary Tumor Growth And Normalizes Immune Balance In Tumor-Bearing Mice
5. Vion Demonstrates Readiness Of First Tumor-Targeting Salmonella For Human Testing Against Solid Tumors
6. Compounds From Fruits, Vegetables And Grains Slow The Growth Of Human Tumor Cells
7. New Cell Isolation Method Will Aid In Studying Tumor Development
8. Wistar Institute To Host 3rd International Conference On Molecular And Clinical Genetics Of Childhood Renal Tumors And The Mitchell Ross Symposium
9. Scientists Study Proteins Role In Tumor Development In Fish
10. Fly Tumor Points Way To New Understanding Of Cancer Development
11. Vions TAPET Organisms Demonstrate Reduced Virulence, Increased Safety While Retaining Ability To Specifically Target Tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/10/2017)... CALIF. (PRWEB) , ... October 10, 2017 , ... San ... part of its corporate rebranding initiative announced today. The bold new look is ... reach, as the company moves into a significant growth period. , It will also ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings announced ... by which its ProCell stem cell therapy prevents ... ischemia.  The Company, demonstrated that treatment with ProCell ... limbs saved as compared to standard bone marrow ... HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
Cached News: